VANDA PHARMACEUTICALS INC. Increase (Decrease) in Inventories
VANDA PHARMACEUTICALS INC. (VNDA) reported Increase (Decrease) in Inventories of -$197.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $97.00K, a 73.64% decline year-over-year.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$294.00K, a 115.89% decline year-over-year.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $1.28M, a 1096.26% increase year-over-year.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$32.00K, a 114.95% decline year-over-year.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2025 was $3.47M, a 11851.72% increase from fiscal 2024.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2024 was $29.00K, a 96.24% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2023 was $771.00K, a 82.79% decline from fiscal 2022.
- VANDA PHARMACEUTICALS INC. increase (decrease) in inventories for fiscal 2022 was $4.48M, a 100.58% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$197.00K 10-Q · filed 2026-08-06 | $1.08M derived: sum of 3 quarters · filed 2026-08-06 | $1.05M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$294.00K 10-Q · filed 2026-05-07 | $986.00K derived: sum of 2 quarters · filed 2026-05-07 | $954.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.25M derived: sum of 2 quarters · filed 2026-02-12 | $1.62M derived: sum of 3 quarters · filed 2026-08-06 | $3.47M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $336.00K derived: sum of 2 quarters · filed 2026-08-06 | $2.19M 10-Q · filed 2025-10-30 | $2.29M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.22M 10-Q · filed 2026-08-06 | $2.33M derived: sum of 3 quarters · filed 2026-08-06 | $2.54M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $1.85M 10-Q · filed 2026-05-07 | $1.96M derived: sum of 2 quarters · filed 2026-05-07 | $2.17M derived: sum of 3 quarters · filed 2026-05-07 | $1.91M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $321.00K derived: sum of 2 quarters · filed 2026-02-12 | $58.00K derived: sum of 3 quarters · filed 2026-02-12 | $29.00K 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$49.00K derived: sum of 2 quarters · filed 2025-10-30 | -$78.00K 10-Q · filed 2025-10-30 | $349.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | -$263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$292.00K 10-Q · filed 2025-07-31 | $135.00K derived: sum of 3 quarters · filed 2026-02-12 | $689.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | -$29.00K 10-Q · filed 2025-05-08 | $398.00K derived: sum of 2 quarters · filed 2026-02-12 | $952.00K derived: sum of 3 quarters · filed 2026-02-12 | $816.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $981.00K derived: sum of 2 quarters · filed 2026-02-12 | $845.00K derived: sum of 3 quarters · filed 2026-02-12 | $771.00K 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $418.00K derived: sum of 2 quarters · filed 2024-11-07 | $344.00K 10-Q · filed 2024-11-07 | $1.47M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$210.00K 10-Q · filed 2024-08-01 | $920.00K derived: sum of 3 quarters · filed 2025-02-14 | $2.69M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-09 | $1.06M derived: sum of 2 quarters · filed 2025-02-14 | $2.82M derived: sum of 3 quarters · filed 2025-02-14 | $3.23M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $2.90M derived: sum of 2 quarters · filed 2025-02-14 | $3.30M derived: sum of 3 quarters · filed 2025-02-14 | $4.48M 10-K · filed 2025-02-14 | |||
| 2022-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.17M derived: sum of 2 quarters · filed 2023-11-09 | $3.35M 10-Q · filed 2023-11-09 | $3.43M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-06-30 | $403.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $1.58M 10-Q · filed 2023-07-28 | $1.66M derived: sum of 3 quarters · filed 2024-02-08 | $2.45M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-03 | $1.26M derived: sum of 2 quarters · filed 2024-02-08 | $2.05M derived: sum of 3 quarters · filed 2024-02-08 | $3.45M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2021-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $867.00K derived: sum of 2 quarters · filed 2024-02-08 | $2.27M derived: sum of 3 quarters · filed 2024-02-08 | $2.23M 10-K · filed 2024-02-08 | |||
| 2021-09-30 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.20M derived: sum of 2 quarters · filed 2022-11-03 | $2.16M 10-Q · filed 2022-11-03 | $1.90M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.37M 10-Q · filed 2022-08-04 | $1.11M derived: sum of 3 quarters · filed 2023-02-09 | $4.25M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-03-31 | -$42.00K 10-Q · filed 2022-05-06 | -$294.00K derived: sum of 2 quarters · filed 2023-02-09 | $2.84M derived: sum of 3 quarters · filed 2023-02-09 | $2.91M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | -$252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $2.89M derived: sum of 2 quarters · filed 2023-02-09 | $2.95M derived: sum of 3 quarters · filed 2023-02-09 | $2.88M 10-K · filed 2023-02-09 | |||
| 2020-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.20M derived: sum of 2 quarters · filed 2021-11-04 | $3.13M 10-Q · filed 2021-11-04 | $2.95M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$10.00K 10-Q · filed 2021-07-29 | -$184.00K derived: sum of 3 quarters · filed 2022-02-24 | $521.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$76.00K 10-Q · filed 2021-05-06 | -$250.00K derived: sum of 2 quarters · filed 2022-02-24 | $455.00K derived: sum of 3 quarters · filed 2022-02-24 | $602.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $531.00K derived: sum of 2 quarters · filed 2022-02-24 | $678.00K derived: sum of 3 quarters · filed 2022-02-24 | $722.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $705.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $852.00K derived: sum of 2 quarters · filed 2020-10-29 | $896.00K 10-Q · filed 2020-10-29 | $1.04M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $191.00K 10-Q · filed 2020-08-06 | $336.00K derived: sum of 3 quarters · filed 2021-02-11 | $50.00K derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-03-31 | $44.00K 10-Q · filed 2020-05-07 | $189.00K derived: sum of 2 quarters · filed 2021-02-11 | -$97.00K derived: sum of 3 quarters · filed 2021-02-11 | $37.00K derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2018-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$141.00K derived: sum of 2 quarters · filed 2021-02-11 | -$7.00K derived: sum of 3 quarters · filed 2021-02-11 | -$70.00K 10-K · filed 2021-02-11 | |||
| 2018-09-30 | -$286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$152.00K derived: sum of 2 quarters · filed 2019-11-07 | -$215.00K 10-Q · filed 2019-11-07 | -$51.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $71.00K 10-Q · filed 2019-08-01 | $235.00K derived: sum of 3 quarters · filed 2020-02-26 | $1.12M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | -$63.00K 10-Q · filed 2019-05-03 | $101.00K derived: sum of 2 quarters · filed 2020-02-26 | $990.00K derived: sum of 3 quarters · filed 2020-02-26 | $914.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.05M derived: sum of 2 quarters · filed 2020-02-26 | $977.00K derived: sum of 3 quarters · filed 2020-02-26 | $1.06M 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $889.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $813.00K derived: sum of 2 quarters · filed 2018-11-07 | $896.00K 10-Q · filed 2018-11-07 | $759.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $7.00K 10-Q · filed 2018-08-02 | -$130.00K derived: sum of 3 quarters · filed 2019-02-19 | -$456.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-03-31 | $83.00K 10-Q · filed 2018-05-02 | -$54.00K derived: sum of 2 quarters · filed 2019-02-19 | -$380.00K derived: sum of 3 quarters · filed 2019-02-19 | -$75.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2016-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$463.00K derived: sum of 2 quarters · filed 2019-02-19 | -$158.00K derived: sum of 3 quarters · filed 2019-02-19 | -$200.00K 10-K · filed 2019-02-19 | |||
| 2016-09-30 | -$326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$21.00K derived: sum of 2 quarters · filed 2017-11-08 | -$63.00K 10-Q · filed 2017-11-08 | $3.00K derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-06-30 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $263.00K 10-Q · filed 2017-08-03 | $109.00K 10-Q · filed 2016-07-28 | $329.00K derived: sum of 3 quarters · filed 2018-02-15 | $84.00K derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-03-31 | -$42.00K 10-Q · filed 2017-05-03 | -$130.00K 10-Q · filed 2016-05-05 | $24.00K derived: sum of 2 quarters · filed 2018-02-15 | -$221.00K derived: sum of 3 quarters · filed 2018-02-15 | -$474.00K derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$179.00K derived: sum of 2 quarters · filed 2018-02-15 | -$432.00K derived: sum of 3 quarters · filed 2018-02-15 | -$387.00K 10-K · filed 2018-02-15 | |||
| 2015-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$498.00K derived: sum of 2 quarters · filed 2016-11-03 | -$453.00K 10-Q · filed 2016-11-03 | -$1.37M 10-Q · filed 2015-11-04 | $489.00K derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-06-30 | -$253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$208.00K 10-Q · filed 2016-07-28 | $734.00K derived: sum of 3 quarters · filed 2017-02-17 | $909.00K derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-05 | $987.00K derived: sum of 2 quarters · filed 2017-02-17 | $1.16M derived: sum of 3 quarters · filed 2017-02-17 | $2.06M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2014-12-31 | $942.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.12M derived: sum of 2 quarters · filed 2017-02-17 | $2.02M derived: sum of 3 quarters · filed 2017-02-17 | $2.21M 10-K · filed 2017-02-17 | |||
| 2014-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.08M derived: sum of 2 quarters · filed 2015-11-04 | $1.27M 10-Q · filed 2015-11-04 | ||||
| 2014-06-30 | $901.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.09M 10-Q · filed 2015-07-31 | |||||
| 2014-03-31 | $192.00K 10-Q · filed 2015-05-07 | ||||||
| 2012-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$108.00K derived: sum of 2 quarters · filed 2013-02-26 | $57.00K 10-K · filed 2013-02-26 | ||||
| 2012-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $161.00K 10-Q · filed 2012-11-08 | |||||
| 2012-06-30 | $165.00K 10-Q · filed 2012-08-03 | ||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $0.00 derived: sum of 2 quarters · filed 2013-02-26 | -$2.40M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$2.40M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | -$2.40M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $2.40M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |